跳至主要内容
临床试验/NCT01060319
NCT01060319撤回不适用

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Stanford University1 个研究点 分布在 1 个国家开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Measurement of cancer stem cells (CSCs)

研究概览

简要总结

We hypothesize that all human malignancies harbour a subpopulation of tumor initiating cells/cancer stem cells (CSCs) that drives tumor development and potentially recurrence or metastasis of the disease. The primary aim of this study is to develop strategies for prospective isolation/enrichment of CSCs from human tumors of different tissue origins. In addition, we will characterize the signaling pathways and/or tumor specific antigens that are specific for CSCs, in order to specifically target these CSCs as the endpoint of this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • N/A. We will recruit all non-melanoma skin and bladder cancer patients that are recommended for surgical removal of tumor tissues. This includes patients from all ages, gender and ethnicity background. Our sample collection criteria based on the tumor size of individual (e.g. tumor samples will only be collected if it will not affect the pathological diagnosis or treatment procedures of patients).

排除标准

  • 未提供

结局指标

主要结局

Measurement of cancer stem cells (CSCs)

时间窗: The current study does not include the active involvement of patients. Our study involves the collection of tumor samples from patients after surgical procedures.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Comprehensive Study to Isolate Tumor-initiating... | 临床试验